Reprise Biomedical

Reprise Biomedical, Inc. is a small company based in Plymouth, Minnesota, with a team of four employees. Established in July 2019 as a spin-off from Miromatrix Medical Inc., Reprise Biomedical specializes in the development and commercialization of biological medical devices. The company offers a range of products designed to advance healing solutions, including MiroDerm biologic wound matrix, MiroFlex biologic matrix for soft tissue reinforcement, and their newest addition, Miro3D wound matrix. These products cater to various surgical needs, particularly focusing on wound management. Reprise Biomedical distinguishes itself through its proprietary perfusion decellularization technology, enabling the creation of innovative medical devices. This technology drives the company's commitment to addressing unmet surgical needs for healing. For inquiries or further information, interested parties can visit Reprise Biomedical's website at reprisebio.com.